Literature DB >> 18159257

Rotavirus vaccine withdrawal in the United states; the role of postmarketing surveillance.

G Delage.   

Abstract

Year:  2000        PMID： 18159257      PMCID： PMC2094741          DOI： 10.1155/2000/414396

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  14 in total

1.  Withdrawal of rotavirus vaccine recommendation.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-11-05       Impact factor: 17.586

2.  Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code.

Authors:  U D Parashar; R C Holman; M J Clarke; J S Bresee; R I Glass
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

3.  Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations.

Authors:  M Santosham; L H Moulton; R Reid; J Croll; R Weatherholt; R Ward; J Forro; E Zito; M Mack; G Brenneman; B L Davidson
Journal:  J Pediatr       Date:  1997-10       Impact factor: 4.406

4.  The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden.

Authors:  R I Glass; P E Kilgore; R C Holman; S Jin; J C Smith; P A Woods; M J Clarke; M S Ho; J R Gentsch
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

5.  Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.

Authors:  I Pérez-Schael; M J Guntiñas; M Pérez; V Pagone; A M Rojas; R González; W Cunto; Y Hoshino; A Z Kapikian
Journal:  N Engl J Med       Date:  1997-10-23       Impact factor: 91.245

Review 6.  Rotavirus vaccines: an overview.

Authors:  K Midthun; A Z Kapikian
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

7.  Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.

Authors:  D I Bernstein; R I Glass; G Rodgers; B L Davidson; D A Sack
Journal:  JAMA       Date:  1995-04-19       Impact factor: 56.272

8.  Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124

9.  Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.

Authors:  J Joensuu; E Koskenniemi; X L Pang; T Vesikari
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

10.  Trends of diarrheal disease--associated mortality in US children, 1968 through 1991.

Authors:  P E Kilgore; R C Holman; M J Clarke; R I Glass
Journal:  JAMA       Date:  1995-10-11       Impact factor: 56.272
View more
  12 in total

1.  Assessing immunization programs.

Authors:  Joanne Embree
Journal:  Can J Infect Dis       Date:  2002-07

2.  Assessing immunization programs.

Authors:  Joanne Embree
Journal:  Paediatr Child Health       Date:  2002-11       Impact factor: 2.253

3.  Adapting Syndromic Surveillance Baselines After Public Health Interventions.

Authors:  Roger Antony Morbey; Alex James Elliot; Gillian Elizabeth Smith; Andre Charlett
Journal:  Public Health Rep       Date:  2020-10-07       Impact factor: 2.792

Review 4.  Recommendations and barriers to vaccination in systemic lupus erythematosus.

Authors:  Megha Garg; Naaima Mufti; Tara N Palmore; Sarfaraz A Hasni
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

5.  Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol.

Authors:  Samarasimha Reddy; Nayana P Nair; Sidhartha Giri; Venkata Raghava Mohan; Jacqueline E Tate; Umesh D Parashar; Mohan D Gupte; Rashmi Arora; Gagandeep Kang
Journal:  BMC Public Health       Date:  2018-07-20       Impact factor: 3.295

6.  Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans.

Authors:  Veena Hoffman; Remon Abu-Elyazeed; Cheryl Enger; Daina B Esposito; Michael C Doherty; Scott C Quinlan; Kathleen Skerry; Crystal N Holick; Peter Basile; Leonard R Friedland; Nicolas Praet; Stéphanie Wéry; Corinne Willame; David D Dore; Dominique Rosillon
Journal:  Hum Vaccin Immunother       Date:  2018-04-13       Impact factor: 3.452

Review 7.  A review of the safety of vaccines used in routine immunization in Africa.

Authors:  Peter Yamoah; Varsha Bangalee; Frasia Oosthuizen
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

8.  Intussusception in children under five years of age in Enugu, Nigeria.

Authors:  Beckie Nnenna Tagbo; Uchechukwu Obiora Ezomike; Oluwatoyin Arinola Odetunde; Benedict Onyeka Edelu; Bismarck Christopher Eke; Ogechukwu Francesca Amadi; Ifeyinwa Bernadette Okeke; Okechukwu Ani; Chinedu Michael Chukwubuike; Jason Mathiu Mwenda; Sebastian Okwuchukwu Ekenze
Journal:  Pan Afr Med J       Date:  2021-08-06

Review 9.  The dichotomy of pathogens and allergens in vaccination approaches.

Authors:  Fiona J Baird; Andreas L Lopata
Journal:  Front Microbiol       Date:  2014-07-16       Impact factor: 5.640

10.  Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data.

Authors:  Giulia Bonaldo; Roberta Noseda; Alessandro Ceschi; Alberto Vaccheri; Domenico Motola
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.